Ultra-Sensitive Diagnostics 

Diagnostics at Your Fingertips

High through-put chemistry and point-of-care testing.

We bring ultra-sensitive diagnostics to laboratories and remote settings where patients and healthcare providers depend on accurate and rapid results.


Illucidx strives to develop tools that deliver truly useful diagnostics strategies. We prioritize feasibility, visual detection, near-patient deployment, shelf stability, rapid turnaround time and high sensitivity and specificity.

 

Diagnostic Solutions for Various Pathogens

Ultra-sensitive, rapid, dynamic, and customizable pathogen detection.

Malaria

Developing new ultra-sensitive diagnostics to address the needs of low and middle-income countries.

COVID-19

Responding to the global need for more high through-put laboratory and point-of-care diagnostic solutions.

Resistant Organisms

Detecting organisms like carbapenem-resistant organisms (CRO) in the global fight against antimicrobial resistance.

Diagnostic Options

High Throughput Diagnostic Chemistry

Illucidx can offer a simpler and cheaper alternative to PCR with a comparable or better level of detection. Our services can provide primers, reagents, and consulting to help your lab use commonly available diagnostic laboratory equipment to run isothermal pathogen detection tests. This is particularly relevant as our chemistry does not use many of the qPCR reagents that are subject to supply chain shortages during the current COVID-19 pandemic.

Near-Patient & Point-of-Care Testing

Illucidx is developing rapid diagnostics that can be taken into the field and to near-patient applications. We want to allow ultra-sensitive nucleic acid detection diagnostics to be performed anywhere without the need for a laboratory or expensive equipment. 

 

A rapidly growing company

Why Choose Illucidx Inc.

Mission: To provide ultra-sensitive state-of-the-art infectious diseases diagnostics to remote clinical settings.

 

Illucidx's number one priority is to provide diagnostics that can positively affect clinical and patient outcomes.

 

We are a social enterprise committed to developing state-of-the-art tools for developed countries. However, we also recognize the need for ultra-sensitive diagnostic options that can be realistically deployed in low and middle-income countries. Hence, it is important that our tests are robust, field deployable, and economical.

 

Latest News

Validating COVID-19 Diagnostic

We have developed multiple options for COVID-19 detection in patient samples. Our chemistry for high throughput laboratories is being clinically validated for Health Canada and FDA EUA approval. 

COVID-19 Point-of-Care Test Under Development

We are rapidly developing a true point-of-care diagnostic solution that can be brought to rural health clinics, utilized by EMS, and act as a crucial tool at ports of entry.

Ultra-Sensitive Malaria Diagnostic

Work is underway to bring our ultra-sensitive malaria detection chemistry to a cartridge-based design. Stay tuned for updates on development.

  

 

Contact Us

Want to hear more about our products, place an order, or speak to a representative about collaboration or a diagnostic need. Please use the form below.

  • LinkedIn
 
LogoMakr-0D12bz-300dpi_edited.png

Headquartered in Calgary, Alberta, Canada we hope to enable broad access to ultra-sensitive diagnostics tools for settings across the globe. Our first priority is, and will always remain, to improve clinical outcomes.

Please email for direct number

 

3655 36 St NW 

Calgary, AB T2L 1Y8

Canada

  • LinkedIn

© 2020 Illucidx Inc Previously Elucidx Inc.